Antibiotic prescribing: How can emergence of antibiotic resistance be delayed?

Australian Prescriber

Volumn 27, Issue 2, 2004, Pages

  Ferguson, John ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Drug utilisation

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM; CIPROFLOXACIN; FUSIDIC ACID; GLYCOPEPTIDE; METICILLIN; RIFAMPICIN; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG UTILIZATION; ENTEROCOCCUS; GENE DELETION; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; NONHUMAN; OUTCOMES RESEARCH; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; UPPER RESPIRATORY TRACT INFECTION; WOUND INFECTION;

EID: 1942489035     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2004.037     Document Type: Review

References (14)

1. Turnidge J. Antibiotics in animals - much ado about something. Aust Prescr 2001;24:26-7.
2. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
3. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000;45:895-8.
4. McNulty C, Logan M, Donald IP, Ennis D, Taylor D, Baldwin RN, et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 1997;40:707-11.
5. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-6.
6. Writing group for Therapeutic Guidelines: Antibiotic. Therapeutic Guidelines: Antibiotic. 12th edition. Melbourne: Therapeutic Guidelines Ltd.; 2003.
7. Wunderink RG, Woldenberg LS, Zeiss J, Day CM, Ciemins J, Lacher DA. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992;101:458-63.
8. Little P, Gould C, Moore M, Warner G, Dunleavey J, Williamson I. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. Br Med J 2002;325:22.
9. Kaleida PH, Casselbrant ML, Rockette HE, Paradise JL, Bluestone CD, Blatter MM, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991;87:466-74.
10. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001;108:239-47
11. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR 1995 Sept 22;44(RR-12):1-13.
12. Ashley D, Watson R. Antibiotic guidelines: improved implementation is the challenge. Med J Aust 2002;176:513-4.
13. Tiley S, Ferguson J. Surveillance of antimicrobial utilisation. Aust Infect Control J 2003;8:3-4.
14. Australian Infection Control Association National Advisory Board. Draft surveillance indicator definitions: antimicrobial utilisation. Aust Infect Control J 2001;6:134-5.